These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21900030)

  • 21. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study.
    Morandi A; Maschio M; Marigliano M; Miraglia Del Giudice E; Moro B; Peverelli P; Maffeis C
    Pediatr Obes; 2014 Feb; 9(1):17-25. PubMed ID: 23296488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
    Davey Smith G; Bracha Y; Svendsen KH; Neaton JD; Haffner SM; Kuller LH;
    Ann Intern Med; 2005 Mar; 142(5):313-22. PubMed ID: 15738450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study.
    Sicree RA; Zimmet PZ; Dunstan DW; Cameron AJ; Welborn TA; Shaw JE
    Diabet Med; 2008 Mar; 25(3):296-302. PubMed ID: 18307457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
    Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
    Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of Croí MyAction community lifestyle modification programme compared to standard care to reduce progression to diabetes/pre-diabetes in women with prior gestational diabetes mellitus (GDM): study protocol for a randomised controlled trial.
    Infanti JJ; Dunne FP; O'Dea A; Gillespie P; Gibson I; Glynn LG; Noctor E; Newell J; McGuire BE
    Trials; 2013 May; 14():121. PubMed ID: 23782471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness.
    Viitasalo K; Hemiö K; Puttonen S; Hyvärinen HK; Leiviskä J; Härmä M; Peltonen M; Lindström J
    Prim Care Diabetes; 2015 Apr; 9(2):96-104. PubMed ID: 25128324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
    Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
    PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes.
    Struijk EA; Heraclides A; Witte DR; Soedamah-Muthu SS; Geleijnse JM; Toft U; Lau CJ
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):822-8. PubMed ID: 22831954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.
    Eriksson KF; Lindgärde F
    Diabetologia; 1998 Sep; 41(9):1010-6. PubMed ID: 9754818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.
    Eriksson J; Lindström J; Valle T; Aunola S; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Lauhkonen M; Lehto P; Lehtonen A; Louheranta A; Mannelin M; Martikkala V; Rastas M; Sundvall J; Turpeinen A; Viljanen T; Uusitupa M; Tuomilehto J
    Diabetologia; 1999 Jul; 42(7):793-801. PubMed ID: 10440120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
    Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese.
    Noda M; Kato M; Takahashi Y; Matsushita Y; Mizoue T; Inoue M; Tsugane S; Kadowaki T
    Endocr J; 2010; 57(7):629-37. PubMed ID: 20508383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: A three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups.
    Pérez-Ferre N; Del Valle L; Torrejón MJ; Barca I; Calvo MI; Matía P; Rubio MA; Calle-Pascual AL
    Clin Nutr; 2015 Aug; 34(4):579-85. PubMed ID: 25262459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.
    Hernestål-Boman J; Norberg M; Jansson JH; Eliasson M; Eriksson JW; Lindahl B; Johansson L
    Cardiovasc Diabetol; 2012 Dec; 11():152. PubMed ID: 23249721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.